ADC Therapeutics (ADCT) News Today $3.12 +0.01 (+0.16%) As of 03:17 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ADCT Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period ADC Therapeutics SA (NYSE:ADCT) Receives $7.75 Consensus Price Target from BrokeragesAugust 19 at 2:17 AM | americanbankingnews.comWall Street Zen Downgrades ADC Therapeutics (NYSE:ADCT) to SellAugust 18 at 2:11 AM | americanbankingnews.comCantor Fitzgerald Brokers Raise Earnings Estimates for ADCTAugust 17, 2025 | marketbeat.comADC Therapeutics SA (NYSE:ADCT) Receives Consensus Recommendation of "Buy" from AnalystsAugust 17, 2025 | marketbeat.comADC Therapeutics (NYSE:ADCT) Downgraded to "Sell" Rating by Wall Street ZenAugust 17, 2025 | marketbeat.comADC Therapeutics (NYSE:ADCT) Given "Buy" Rating at GuggenheimAugust 15, 2025 | marketbeat.comADC Therapeutics (NYSE:ADCT) Announces Quarterly Earnings Results, Misses Expectations By $0.14 EPSAugust 13, 2025 | marketbeat.comADC Therapeutics S.A. (NYSE:ADCT) Q2 2025 Earnings Call TranscriptAugust 13, 2025 | msn.comADC Therapeutics SA (ADCT) Q2 2025 Earnings Call Highlights: Revenue Growth Amid Strategic ...August 13, 2025 | gurufocus.comADC Therapeutics SA (ADCT) Q2 2025 Earnings Call TranscriptAugust 12, 2025 | seekingalpha.comADC Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational UpdateAugust 12, 2025 | gurufocus.comADC Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational UpdateAugust 12, 2025 | prnewswire.comPreview: ADC Therapeutics's EarningsAugust 12, 2025 | benzinga.comADC Therapeutics to Host Second Quarter 2025 Financial Results Conference Call on August 12, 2025August 5, 2025 | prnewswire.comADC Therapeutics Makes Grants to New Employees Under Inducement PlanAugust 1, 2025 | gurufocus.comADC Therapeutics Makes Grants to New Employees Under Inducement PlanAugust 1, 2025 | prnewswire.comADC Therapeutics (ADCT) Expected to Announce Quarterly Earnings on TuesdayJuly 29, 2025 | marketbeat.comADC Therapeutics S.A. Financials | ADCT | Barron'sJuly 12, 2025 | barrons.comADC Therapeutics (NYSE:ADCT) Shares Down 4.2% - Here's WhyJuly 12, 2025 | marketbeat.comADC Therapeutics Makes Grant to New Employee Under Inducement PlanJuly 1, 2025 | prnewswire.comADCT - ADC Therapeutics SA Financials - MorningstarJune 26, 2025 | morningstar.comMRBC Capital Sticks to Its Buy Rating for ADC Therapeutics (ADCT)June 22, 2025 | theglobeandmail.comADC Therapeutics price target lowered to $5 at RBC on growth outlookJune 21, 2025 | investing.comADC Therapeutics (NYSE:ADCT) Price Target Lowered to $5.00 at Royal Bank Of CanadaJune 20, 2025 | marketbeat.comADC Therapeutics (NYSE:ADCT) HeadlineJune 16, 2025 | gurufocus.comADC Therapeutics Announces Updated ZYNLONTA® Investigator-Initiated Trial Data in R/R Marginal Zone Lymphoma Presented at 18th International Conference on Malignant Lymphoma (ICML)June 16, 2025 | prnewswire.comADC Therapeutics (NYSE:ADCT) Price Target Raised to $10.00 at GuggenheimJune 13, 2025 | marketbeat.comADC reports data from lymphoma trial, streamlines operationsJune 12, 2025 | msn.comADC Therapeutics Announces $100 Million Private Placement Extending Expected Cash Runway into 2028June 12, 2025 | prnewswire.comADC Therapeutics Announces Updated Data from LOTIS-7 Clinical Trial Presented at the European Hematology Association 2025 CongressJune 12, 2025 | prnewswire.comBrokers Issue Forecasts for ADCT FY2026 EarningsJune 11, 2025 | marketbeat.comWellington Management Group LLP Purchases 84,785 Shares of ADC Therapeutics SA (NYSE:ADCT)June 8, 2025 | marketbeat.comMillennium Management LLC Decreases Stock Position in ADC Therapeutics SA (NYSE:ADCT)June 7, 2025 | marketbeat.comADC Therapeutics Makes Grants to New Employees Under Inducement PlanJune 2, 2025 | prnewswire.comBank of America Corp DE Has $2.57 Million Position in ADC Therapeutics SA (NYSE:ADCT)June 2, 2025 | marketbeat.comWoodline Partners LP Takes $3.85 Million Position in ADC Therapeutics SA (NYSE:ADCT)May 27, 2025 | marketbeat.comBNP Paribas Financial Markets Purchases Shares of 716,668 ADC Therapeutics SA (NYSE:ADCT)May 21, 2025 | marketbeat.comFY2025 EPS Estimates for ADCT Increased by Cantor FitzgeraldMay 21, 2025 | marketbeat.comAnalysts Are Upgrading ADC Therapeutics SA (NYSE:ADCT) After Its Latest ResultsMay 17, 2025 | finance.yahoo.comADC Therapeutics SA (NYSE:ADCT) Q1 2025 Earnings Call TranscriptMay 15, 2025 | msn.comADC Therapeutics ends development of ADCT-602 and unveils latest Zynlonta dataMay 15, 2025 | finance.yahoo.comOrbimed Advisors LLC Grows Position in ADC Therapeutics SA (NYSE:ADCT)May 15, 2025 | marketbeat.comADC Therapeutics to Present at Upcoming Investor ConferencesMay 15, 2025 | prnewswire.comADC Therapeutics signals data catalysts ahead with ZYNLONTA combinations, aims for regulatory milestones through 2025May 14, 2025 | msn.comADC Therapeutics Announces Presentation of LOTIS-7 Clinical Trial Data at the European ...May 14, 2025 | gurufocus.comADC Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational UpdateMay 14, 2025 | gurufocus.comADC Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational UpdateMay 14, 2025 | prnewswire.comADC Therapeutics Announces Presentation of LOTIS-7 Clinical Trial Data at the European Hematology Association 2025 Congress (EHA2025) and the 18th International Conference on Malignant Lymphoma (ICML)May 14, 2025 | prnewswire.com6ADCT : Preview: ADC Therapeutics's EarningsMay 13, 2025 | benzinga.comADC Therapeutics to Host First Quarter 2025 Financial Results Conference Call on May 14, 2025May 8, 2025 | prnewswire.com Get ADC Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ADCT and its competitors with MarketBeat's FREE daily newsletter. Email Address ADCT Media Mentions By Week ADCT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADCT News Sentiment▼0.640.50▲Average Medical News Sentiment ADCT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADCT Articles This Week▼92▲ADCT Articles Average Week Get ADC Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ADCT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AMPH News VERA News ABCL News ETNB News SNDX News COGT News EVO News AVDL News PAHC News XERS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ADCT) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ADC Therapeutics SA Please log in to your account or sign up in order to add this asset to your watchlist. Share ADC Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access